Hepatocellular carcinoma (HCC) is the most frequent liver neoplasm, and its incidence rates
are constantly increasing. Despite the availability of potentially curative treatments (liver …

Hepatocellular carcinoma (HCC) is the fifth most common cancer globally and the fourth
most common cancer in men in Korea, where the prevalence of chronic hepatitis B infection …

This guidance document provides an updated approach to the prevention, diagnosis, and
treatment of hepatocellular carcinoma (HCC). The prior American Association for the Study …

Background & Aims Outcomes of liver transplantation for hepatocellular carcinoma (HCC)
are determined by cancer-related and non-related events. Treatments for hepatitis C virus …

Liver transplantation for hepatocellular carcinoma (HCC) is the best treatment option for
patients with early-stage tumours and accounts for∼ 20–40% of all liver transplantations …

Hepatocellular carcinoma (HCC) is the fifth most common cancer worldwide and the fourth
most common cancer among men in South Korea, where the prevalence of chronic hepatitis …

The neutrophil-to-lymphocyte ratio (NLR) is an inflammatory marker which has been
investigated as a prognostic indicator in post-therapeutic recurrence and survival of patients …

Liver transplantation is a highly complex and challenging field of clinical practice. Although it
was originally developed in western countries, it has been further advanced in Asian …

Liver transplantation is the best treatment option for cirrhotic patients with early-stage
hepatocellular carcinoma, but it faces the problem of scarcity of donors and the risk of tumor …

Background and purpose Tumor recurrence after liver transplantation (LT) impedes the
curative chance for hepatocellular carcinoma (HCC) patients. This study aimed to develop a …